Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Effectiveness of Brilliant Blue G in Vitreoretinal Surgeries (EEBVS)
jRCTs021180004Completed
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of brilliant blue G in cataract and vitreoretinal disease (VRD). Primary endpoint: Visual acuity. Started Nov 2013; status: completed.
02
Drugs
brilliant blue G
03
Conditions
cataractvitreoretinal disease (VRD)
Beyond the preview
Go deeper on jRCTs021180004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs021180004.